More recently, apoA1 has been identified as marker of AD, with the concentration of apoA1 in cerebrospinal fluid distinguishing AD from non-demented subjects with 84% sensitivity and 72% specificity, with 78% of the subjects being correctly classified (59). This evidence concerns the gene APOA1 and Alzheimer disease.